Objective. In an effort to improve on the results of radical prostatec
tomy for clinical stages T2b and T3 prostate cancer, a selected group
of patients received androgen deprivation for three to sixteen months
prior to surgery. Methods. Fifteen men with clinical T2b and 22 with s
mall T3 tumors received a luteinizing hormone-releasing hormone analog
(n = 34) or a bilateral orchiectomy (n = 3) three to sixteen months p
rior to radical retropubic prostatectomy. The prostate was evaluated w
ith particular attention to tumor grade, presence of extracapsular ext
ension, tumor at the inked margin, seminal vesicle invasion, and tumor
in the lymph nodes. Results. No patient had clinical or chemical (pro
state-specific antigen [PSA]) progression during androgen deprivation.
The PSA level declined a mean 90 percent and remained above 4 ng/mL i
n only two patients. The prostate volume decreased an estimated 30-50
percent. Prostate cancer at the inked margin was found in 15 (41%) and
seminal vesicle,involvement in 11 (30%) patients. Five (14%) had tumo
r in regional lymph nodes. There was no difference in regard to positi
ve margins or lymph node metastases between those clinically staged as
T2b and those preoperatively staged as T3. Fourteen patients have rec
eived adjuvant therapy (13 androgen deprivation, one radiation therapy
). None has progressed (mean follow-up, 38.4 months). Of 23 who did no
t receive immediate additional therapy, six (26%) had progression, as
was evident from an increase in PSA and have since been treated. Only
one continued to progress. Thirty-five of the 37 patients are alive. S
eventeen (46%) are tumor free (PSA < 0.4 ng/mL) without further androg
en deprivation. Conclusions. Only a prospective randomized trial can d
etermine whether androgen deprivation prior to radical prostatectomy h
as a role. The results from this trial are encouraging for several rea
sons. The prostate is much smaller as a result of androgen deprivation
and this may facilitate surgery. Although the great majority of these
patients were expected to be margin positive, 60 percent had negative
margins and only 14 percent had positive lymph nodes.